Monitoring And Controlling Blood Glucose Levels

In the US, diabetes contributes significantly to excess morbidity and mortality. When uncontrolled, it is a major cause of stroke, heart attacks, chronic kidney disease, diabetic retinopathy, neuropathy, and is the major cause of non-traumatic amputations. It is also increases the risk of death two-fold compared to someone without diabetes . However, among those patients with better control, a reduction in hemoglobin A1C has been shown to decrease the risk of kidney disease , progression of CHF , and an overall decrease in microvascular complications . There is a definite benefit of close blood glucose monitoring and control. In type 2 diabetes, characterized by insulin resistance, the standard of care for mild-moderate disease is oral agents, with transition to subcutaneous insulin as the disease progresses. In type 1 diabetes, characterized by lack of insulin, the treatment depends on either an insulin pump or subcutaneous insulin therapy. Unfortunately, in those patients with insulin dependent diabetes, compliance with finger stick glucose measurements is poor, making insulin administration dependent on those measurements imprecise . One solution to this problem that has been proposed is continuous glucose monitoring (CGM). This system consists of a subcutaneously implanted glucose sensor that wirelessly transmits data to a recorder worn on the body. This allows for frequent (generally a few times an

There were three things that I learned from the Diabetes Vendor Fair. The first thing that i found interesting to know was about the clinical glucose assessment tool. This tool is very small like an iPod. It is a single used devices to scan and reports glucose pattern. The doctors and nurses use this sensor applied to the back of the upper arm and activated. Then the patients will wear it home for 14 days. After that, the healthcare professional can connect the reader device to computer and get the report very easy and detail. This sensor is water resistance. Patients can do any daily activities and patients also can swim for up to 30 minutes without any damaged to the sensor. This sensor is about $60 for each patient.

Diabetes is a condition in which the body is unable to control the amount of glucose in the blood stream, because the pancreas does not produce enough insulin hormone. For those who have diabetes, the complex system that regulates blood glucose fails. Glucose cannot enter the body’s cells, and therefore cannot be utilised for energy. “Around 1.7 million Australians have diabetes” (Diabetes Australia, 2015), which is undoubtedly a huge cost burden to the Australian healthcare system. There are different types of Diabetes which ultimately cause glucose to accumulate in the bloodstream to a level which can become harmful to health. At this stage there is no cure for diabetes, although there are factors that influence the condition, such as the environment, genes and lifestyle. In the past efforts to monitor blood glucose levels have proven both invasive and painful. However new technological research in the form of the smart lens may provide improved care and management for those with diabetes in the future.

Diabetes is a continuing unhealthy that needs medical treatment till the last day of life and intervention and support of nurse and adjustment of lifestyle. Diabetes is a disease which is difficult to heal, but possible to be controlled the level of sugar in the blood or urine. It is a dangerous situation for any person where the level of blood sugar elevates and it is one of the most common disruptive that originated in the endocrine. Therefore, this essay is discussing regarding an innovative instrument known as EZSCAN, a monitoring device for the existence of glucose and also debating regarding the experimental outcomes and implication for treatment preparation.

A glucometer is device that is used by diabetics to check their blood sugar. These devices are used by a drop of blood placed on a test strip and the monitor reads it. The finger tip is pricked and the blood

Living with diabetes poses many challenges for patients in areas like nutrition, glycemic monitoring and medication adherence. In fact, patients with diabetes

The benefit of initiated glucose control for critically ill patients is safety and decreasing mortality of the patient and the goal is to start rapid tight glucose control by insulin replacement.

Would providing every Type One Diabetic upon diagnosis a Continuous Glucose monitor be a helpful tool for nurses to help monitor them and provide better care? This proposition was envisioned when my son was first diagnosed in the hospital. The nurses were very conscious about making sure his numbers were within the correct range. Looking at this situation and wondering how it could be made easier on the nurses and patient the CGM just made perfect sense. Why would everyone struggle when this device was made to make everyone’s involvement with Diabetes much easier to handle.

Smart phones can help with everything these days, and the same is true for taking diabetic care. There are many applications that are available on all the famous mobile platforms. These applications help you in keeping track of your medicines, as well as allow you to record your blood sugar values.

Young diabetes may increase their insulin intake up thirty to fifty percent due to hormonal alterations; however, if not properly adjusted, young clients may experience “delayed menarche, impaired growth, menstrual irregularities,” and long-term diabetic complications such as neuropathy, retinopathy, and nephropathy (Trast, 2014). Therefore, they have to check their blood sugar at least 6-8 times a day, and the monitoring is even harder when they are aware that hormonal changes can occur at night. However, technology has progressively advanced, so young diabetics should should take advantage of the insulin pump with RT-CGM (real time continuous glucose monitoring). The pump administers insulin timely, appropriately, and according to RT-CGM, auto-calculates the accurate doses based on personalized preset limits and prevents certain spontaneous hypoglycemia which can cause

As a replacement for the fingerstick glucose testing system for blood, Dexcom G5 launched the Continuous Glucose Monitoring system. It measures the glucose externally through a wearable wire. It has a sensor for projecting the glucose levels. Each sensor has a life of up to 7 days and it keeps reporting real - time updates every 5 minutes. FDA has approved the release and use of this product in the stead of fingerstick blood testers.

Doctors and researchers are findings new cures and solutions save the rising issues of diabetes and bring better health care facilities and technology in the field to help sustain longer, healthier life. As Hovorka, Roman, et al suggest, The technologies include the monitoring devices and the blood test devices that can be used by the patients themselves helping them to keep track of their blood sugar level. The solution does not know the blood sugar level but to act on it accordingly (2006). The use of technology and the development of online records are japing the patients to share their records with the doctors and experts overseas to help them adjusting to new drugs and technological tools.

It is very important to the detect diabetes from early stage as high glucose levels can damage the blood vessels, nerves and organs within the body. Mildly raised glucose levels which don’t cause any symptoms can have

With a specific end goal to accomplish ideal control, patients must screen their blood glucose levels. At present, this obliges a patient to acquire a little example of blood, as a rule through a finger prick. Blood is put onto a sensor test strip that is then read by a handheld electronic reader, which reports the blood glucose concentration. These sensors are based on electrochemical enzymatic estimations (Figure 1) with screen printed cathodes [3] and give quick and exact estimations of blood glucose without the requirement for lab investigation. However, there are constraints to this methodology including, difficult inspecting, examinations cannot be performed if the patient is generally possessed (e.g. sleeping) and expansive changes between examining time focuses are missed [4, 5]. To assist overcome the issues with discrete blood glucose estimation, new glucose detection products concentrate on continuous

Monitoring of the glucose level of diabetic patients is a cornerstone of diabetes care and management. The reliability of the home based glucose monitoring devices is critically important because the whole self-care and management of diabetes depends upon it. But there is still a big question mark on the accuracy of the results of the glucose monitoring devices. The ability of currently marketed glucose monitoring systems to determine the glycemic status of the patient is not very accurate. The glucose monitors detect less accurately than the clinicians usually think. The need for the adjustment of the treatment is greatest when the blood glucose level is in the hypoglycemic range and conversely this is the range of glucose level where the accuracy of the glucose measuring devices falls to the lowest. Various studies have demonstrated the poor performance of the home based glucose monitors in the hypoglycemic and hyperglycemic range. None of the devices in the market fulfills the criteria of accuracy set by American diabetes association and other authorities.